TCRX
Tscan Therapeutics Inc
0.349$
-4.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 1,896.5% | 32.8% | 38.0% | 418.8% | 145.9% | 27.8% | |
| – | -1,796.5% | 100.0% | 100.0% | 100.0% | 100.0% | 72.2% | |
| – | 1,896.5% | 443.3% | 442.0% | 418.8% | 3,812.1% | 1,105.6% | |
| – | 621.3% | 136.4% | 150.4% | 121.1% | 1,049.7% | 309.8% | |
| – | 621.3% | 579.6% | 592.3% | 544.0% | 4,887.7% | 1,387.6% | |
| – | -2,417.8% | -479.6% | -492.3% | -444.0% | -4,787.7% | -1,315.4% | |
| – | 0.0% | 0.2% | 8.7% | 17.9% | 129.7% | 26.8% | |
| – | -2,408.0% | -479.5% | -489.3% | -423.9% | -4,527.7% | -1,256.8% | |
| – | -9.8% | 30.5% | -3.1% | 24.7% | – | – | |
| – | -2,408.0% | -479.5% | -489.3% | -423.9% | -4,527.7% | -1,256.8% | |
| – | -2,304.4% | -446.7% | -442.6% | -380.5% | -4,252.1% | -1,202.2% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.